Effects of raloxifene on the reninâangiotensinâaldosterone system and blood pressure in hypertensive and normotensive osteoporotic postmenopausal women-Reference-Cited by-同舟云学术

Effects of raloxifene on the reninâangiotensinâaldosterone system and blood pressure in hypertensive and normotensive osteoporotic postmenopausal women

Published:2010-01 Issue:1 Volume:10 Page:70-77
ISSN:1444-1586
Container-title:Geriatrics & Gerontology International
language:en
Short-container-title:

Author:

Sumino Hiroyuki,Ichikawa Shuichi,Kasama Shu,Takahashi Takashi,Kumakura Hisao,Takayama Yoshiaki,Kanda Tsugiyasu,Murakami Masami,Kurabayashi Masahiko

Publisher

Wiley

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1447-0594.2009.00562.x/fullpdf

Reference41 articles.

1. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites;Paech;Science,1997

2. An estrogen receptor basis for raloxifene action in bone;Bryant;J Steroid Biochem Mol Biol,1999

3. The effect of raloxifene on risk of breast cancer in postmenopausal women: results from MORE randomized trial: Multiple Outcome of Raloxifene Evaluation;Cummings;JAMA,1999

4. Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial;Barrett-Connor;JAMA,2002

5. Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women;Barrett-Connor;N Engl J Med,2006

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Relationship between Renin–Angiotensin–Aldosterone System (RAAS) Activity, Osteoporosis and Estrogen Deficiency in Type 2 Diabetes;International Journal of Molecular Sciences;2023-07-26

2. Protective effects of combining SERMs with estrogen on metabolic parameters in postmenopausal diabetic cardiovascular dysfunction: The role of cytokines and angiotensin II;Steroids;2022-07

3. Repurposing existing drugs for COVID-19: an endocrinology perspective;BMC Endocrine Disorders;2020-09-29

4. Effects of anti-osteoporosis therapy on plasma aldosterone and renin;Journal of the Renin-Angiotensin-Aldosterone System;2020-04

5. Hormones endogènes et exogènes;La Presse Médicale;2019-11